FAM81A is a postsynaptic protein that regulates the condensation of postsynaptic proteins via liquid-liquid phase separation

PLoS Biol. 2024 Mar 7;22(3):e3002006. doi: 10.1371/journal.pbio.3002006. eCollection 2024 Mar.

Abstract

Proteome analyses of the postsynaptic density (PSD), a proteinaceous specialization beneath the postsynaptic membrane of excitatory synapses, have identified several thousands of proteins. While proteins with predictable functions have been well studied, functionally uncharacterized proteins are mostly overlooked. In this study, we conducted a comprehensive meta-analysis of 35 PSD proteome datasets, encompassing a total of 5,869 proteins. Employing a ranking methodology, we identified 97 proteins that remain inadequately characterized. From this selection, we focused our detailed analysis on the highest-ranked protein, FAM81A. FAM81A interacts with PSD proteins, including PSD-95, SynGAP, and NMDA receptors, and promotes liquid-liquid phase separation of those proteins in cultured cells or in vitro. Down-regulation of FAM81A in cultured neurons causes a decrease in the size of PSD-95 puncta and the frequency of neuronal firing. Our findings suggest that FAM81A plays a crucial role in facilitating the interaction and assembly of proteins within the PSD, and its presence is important for maintaining normal synaptic function. Additionally, our methodology underscores the necessity for further characterization of numerous synaptic proteins that still lack comprehensive understanding.

Publication types

  • Meta-Analysis

MeSH terms

  • Disks Large Homolog 4 Protein / metabolism
  • Phase Separation*
  • Proteome* / metabolism
  • Synapses / metabolism
  • Synaptic Membranes

Substances

  • Proteome
  • Disks Large Homolog 4 Protein

Grants and funding

This work was supported by KAKENHI (JP16H06316, JP16H06463, JP21H04813, JP23H04233 to TT, JP18H05434, JP20K21462, JP22H04981 to YH, JP16J04376, JP18K14830 to TK) from the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Agency for Medical Research and Development (AMED) under Grant Number JP21wm0425011 to TT, Japan Science and Technology Agency (JST) under Grant Number JPMJMS2299, JPMJMS229B to TT, Intramural Research Grant (30-9) for Neurological and Psychiatric Disorders of NCNP, the Takeda Science Foundation, Taiju Life Social Welfare Foundation to TT, and Human Frontier Science Program (RGP0020/2019) to YH. TK was supported by Grant-in-Aid for JSPS Fellows (JP16J04376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.